Pharmaceutical major Wockhardt has bought out Rhein Biotech GmbH from their 50:50 joint venture, Wockhardt Rhein Biopharm, for an undisclosed sum.
Wockhardt will continue to hold a co-exclusive licence on Rhein
Wockhardt Buys Out Rhein Biotech From Joint Venture
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 27 2002 | 12:00 AM IST
